Contact: Heather Buschman, Ph.D.
hbuschman@sanfordburnham.org
858-795-5343
Sanford-Burnham Medical Research Institute

LTV-1 and LYP

Caption: The drug-like chemical compound LTV-1 (foreground) blocks the action of mutant LYP protein in human immune cells, providing a potential new therapeutic for autoimmune diseases.

Credit: Lutz Tautz, Ph.D., Sanford-Burnham Medical Research Institute

Usage Restrictions: Free to use in conjunction with this story only, using provided caption and credit

Related news release: New insight into mechanisms behind autoimmune diseases suggests a potential therapy